Davidson Michael H. Insider Trades

Insider Trading History

Track insider trading activity for Davidson Michael H.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioAge Labs
BioAge Labs BIOA
Director
Holding Value $491k 22,000 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$341k 22,000 shares
$15.48
$22.32
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $19.4M 617,851 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.6M 443,707 shares
$32.83
$31.40
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $5.47M 174,144 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.8M 443,707 shares
$33.25
$31.40
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $7.51M 239,267 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.6M 443,707 shares
$32.83
$31.40
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $3.26M 174,144 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.8M 443,707 shares
$24.30
$18.70
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $11.6M 617,851 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8M 443,707 shares
$24.30
$18.70
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $4.47M 239,267 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8M 443,707 shares
$24.30
$18.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $21.4M 682,974 shares
Last Trade
Feb 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.28M 183,332 shares
$34.28
$31.40
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $15M 477,783 shares
Last Trade
Feb 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.18M 183,332 shares
$33.71
$31.40
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $12M 643,191 shares
Last Trade
Feb 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.76M 183,332 shares
$25.97
$18.70
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $8.93M 477,783 shares
Last Trade
Feb 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.76M 183,332 shares
$25.97
$18.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $20.2M 643,191 shares
Last Trade
Feb 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.28M 183,332 shares
$34.28
$31.40
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $12.8M 682,974 shares
Last Trade
Feb 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.76M 183,332 shares
$25.97
$18.70
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $9.69M 518,112 shares
Last Trade
Feb 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.51M 58,253 shares
$25.97
$18.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $14.8M 471,595 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.06M 58,253 shares
$35.30
$31.40
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $27.2M 866,306 shares
Last Trade
Feb 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.04M 58,253 shares
$35.01
$31.40
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $16.2M 866,306 shares
Last Trade
Feb 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.51M 58,253 shares
$25.97
$18.70
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Executive Officer
Holding Value $16.3M 518,112 shares
Last Trade
Feb 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.04M 58,253 shares
$35.01
$31.40
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $8.82M 471,595 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.51M 58,253 shares
$25.97
$18.70
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Executive Officer
Holding Value $9.81M 524,567 shares
Last Trade
Feb 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.68M 64,708 shares
$25.97
$18.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up